Skip to main content
. 2022 Apr 12;39(6):2701–2716. doi: 10.1007/s12325-022-02119-z

Fig. 1.

Fig. 1

Patient disposition. aTwo patients in each of the fixed and T&E groups and one patient in the PRN group had no post-baseline assessments available and were excluded from the full analysis set. bReasons for withdrawal in the category “Other” were patient withdrawal by sponsor and lack of efficacy. AE adverse event, IVT-AFL intravitreal aflibercept, PRN pro re nata, T&E treat-and-extend